title: The role of PET-CT fusion in head and neck cancer.
abstract: The fusion of 18-fluorodeoxyglucose (FDG) positron-emission tomography (PET) with computed tomography (CT) offers both anatomic and physiologic delineation of head and neck cancers. PET-CT is useful in the staging of head and neck carcinomas and may identify unsuspected distant metastasis that may alter treatment. PET-CT may also help in target volume delineation during radiotherapy (RT) treatment planning. Better characterization of the target may improve local control as well as spare normal tissues from RT sequelae.
authors.affiliation: Department of Radiation Oncology, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
authors.forename: Kyle E
authors.initials: KE
authors.lastname: Rusthoven
authors.forename: Mary
authors.initials: M
authors.lastname: Koshy
authors.forename: Arnold C
authors.initials: AC
authors.lastname: Paulino
mesh_terms: D002277:Carcinoma / Q000000981:diagnostic imaging*; D019788:Fluorodeoxyglucose F18; D006258:Head and Neck Neoplasms / Q000000981:diagnostic imaging* / Q000532:radiotherapy; D006801:Humans; D009367:Neoplasm Staging / Q000379:methods; D010347:Patient Care Planning; D049268:Positron-Emission Tomography; D011832:Radiation Injuries / Q000517:prevention & control; D014057:Tomography, X-Ray Computed
chemical_list: D019788:Fluorodeoxyglucose F18